Characteristics and outcome of patients with primary CNS lymphoma in a "real-life" setting compared to a clinical trial.

about

Increasing incidence of primary central nervous system lymphoma but no improvement in survival in Sweden 2000-2013.

P2860

Q48031561-8459F1D6-8A97-4D03-B087-08D8E541C18B

P2860

Characteristics and outcome of patients with primary CNS lymphoma in a "real-life" setting compared to a clinical trial.

Item

http://www.wikidata.org/entity/Q40071391

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Characteristics and outcome of ...... compared to a clinical trial.

@en

type

Item

label

Characteristics and outcome of ...... compared to a clinical trial.

@en

prefLabel

Characteristics and outcome of ...... compared to a clinical trial.

@en

P1476

Characteristics and outcome of ...... compared to a clinical trial.

@en

P2093

Enrico Schalk

http://www.w3.org/2001/XMLSchema#string

Michael Koehler

http://www.w3.org/2001/XMLSchema#string

Thomas Fischer

http://www.w3.org/2001/XMLSchema#string

Vanja Zeremski

http://www.w3.org/2001/XMLSchema#string

P2860

Nonparametric Estimation from Incomplete Observations

World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Combined-modality therapy for primary central nervous system lymphoma: long-term data from a Phase II multicenter study (Trans-Tasman Radiation Oncology Group).

Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model.

Clinical outcomes of patients with newly diagnosed primary central nervous system lymphoma are comparable on treatment with high-dose methotrexate plus temozolomide and with high-dose methotrexate plus cytarabine: a single-institution experience.

Primary lymphoma of the central nervous system: epidemiology, pathology and current approaches to diagnosis, prognosis and treatment

High-dose methotrexate with or without rituximab in newly diagnosed primary CNS lymphoma.

R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma.

Age, gender, and racial differences in incidence and survival in primary CNS lymphoma.

P304

793-799

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00277-016-2602-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26801791

http://www.w3.org/2001/XMLSchema#string

Characteristics and outcome of patients with primary CNS lymphoma in a "real-life" setting compared to a clinical trial.

about

P2860

P2860

Characteristics and outcome of patients with primary CNS lymphoma in a "real-life" setting compared to a clinical trial.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698